ProQR Therapeutics (PRQR) Change in Account Payables (2013 - 2014)
ProQR Therapeutics recorded quarterly Change in Account Payables of $464552.0 in Q3 2014, up 293.93% quarter-over-quarter from $117928.4 in Q3 2013, and up 293.93% year-over-year from $117928.4 in Q3 2013.
ProQR Therapeutics' Change in Account Payables history runs 2 years deep, the most recent figure standing at $464552.0 for Q3 2014.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 464,552.00 |
| Sep 30, 2014 | 464,552.00 |
| Sep 30, 2013 | 117,928.43 |
| Sep 30, 2013 | 117,928.43 |